Fri Apr 24 MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia Written by PR Newswire Asia - News Pronto RSS Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4941902_CN41902_0
